Literature DB >> 23159128

Evidence-based drug policy: it starts with good evidence and ends with policy reform.

B Nosyk, E Wood.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23159128      PMCID: PMC4570729          DOI: 10.1016/j.drugpo.2012.10.005

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


× No keyword cloud information.
  20 in total

1.  Medicine and the epidemic of incarceration in the United States.

Authors:  Josiah D Rich; Sarah E Wakeman; Samuel L Dickman
Journal:  N Engl J Med       Date:  2011-06-02       Impact factor: 91.245

2.  Let it snow! Let it snow! Let it snow! Estimating cocaine production using a novel dataset based on reported seizures of laboratories in Colombia.

Authors:  Riccardo Leoncini; Francesco Rentocchini
Journal:  Int J Drug Policy       Date:  2012-05-22

3.  Vienna Declaration: a call for evidence-based drug policies.

Authors:  Evan Wood; Dan Werb; Michel Kazatchkine; Thomas Kerr; Catherine Hankins; Robin Gorna; David Nutt; Don Des Jarlais; Françoise Barré-Sinoussi; Julio Montaner
Journal:  Lancet       Date:  2010-07-31       Impact factor: 79.321

4.  Evidence based policy for illicit [corrected] drugs.

Authors:  Evan Wood
Journal:  BMJ       Date:  2010-07-01

5.  Policy resistance to harm reduction for drug users and potential effect of change.

Authors:  Tim Rhodes; Anya Sarang; Peter Vickerman; Matthew Hickman
Journal:  BMJ       Date:  2010-07-13

6.  Stages of drug market change during disaster: Hurricane Katrina and reformulation of the New Orleans drug market.

Authors:  Eloise Dunlap; Jennifer Graves; Ellen Benoit
Journal:  Int J Drug Policy       Date:  2012-06-23

7.  Incremental cost-effectiveness ratios (ICERs): the silence of the lambda.

Authors:  Amiram Gafni; Stephen Birch
Journal:  Soc Sci Med       Date:  2005-12-01       Impact factor: 4.634

8.  'Opioid drought', Canadian-style? Potential implications of the 'natural experiment' of delisting oxycontin in Canada.

Authors:  Benedikt Fischer; Annette Keates
Journal:  Int J Drug Policy       Date:  2012-08-31

9.  Why small-scale cannabis growers stay small: five mechanisms that prevent small-scale growers from going large scale.

Authors:  Eirik Hammersvik; Sveinung Sandberg; Willy Pedersen
Journal:  Int J Drug Policy       Date:  2012-10-01

Review 10.  An evolving problem: methamphetamine production and trafficking in the United States.

Authors:  Rashi K Shukla; Jordan L Crump; Emelia S Chrisco
Journal:  Int J Drug Policy       Date:  2012-09-01
View more
  2 in total

1.  Piloting a 'spatial isolation' index: the built environment and sexual and drug use risks to sex workers.

Authors:  Kathleen N Deering; Melanie Rusch; Ofer Amram; Jill Chettiar; Paul Nguyen; Cindy X Feng; Kate Shannon
Journal:  Int J Drug Policy       Date:  2013-12-22

Review 2.  Cannabinoids and Pain: New Insights From Old Molecules.

Authors:  Sonja Vučković; Dragana Srebro; Katarina Savić Vujović; Čedomir Vučetić; Milica Prostran
Journal:  Front Pharmacol       Date:  2018-11-13       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.